Survival and engraftment of dopaminergic neurons manufactured by a Good Manufacturing Practice-compatible process

Cytotherapy

Volumn 16, Issue 9, 2014, Pages 1305-1312

  Peng, Jun ^a   Liu, Qiuyue ^a   Rao, Mahendra S ^b   Zeng, Xianmin ^a,c  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b NxCell Inc   (United States)

^c XCell Science Inc   (United States)

Author keywords

Cell therapy; Dopaminergic neuron; GMP; Human pluripotent stem cells

Indexed keywords

OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL MATURATION; CELL PRODUCT; CELL SURVIVAL; CELL TRANSPLANTATION; CELL VIABILITY; CELLS; CONTROLLED STUDY; CONVALESCENCE; CORPUS STRIATUM; CRYOPRESERVATION; DONOR; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; ENGRAFTMENT; FEMALE; GOOD MANUFACTURING PRACTICE; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RAT MODEL; SAFETY; ANIMAL; BIOTECHNOLOGY; CELL LINE; DISEASE MODEL; MANUFACTURING INDUSTRY; NERVE FIBER; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; PATHOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; PROCEDURES; SPRAGUE DAWLEY RAT; STEM CELL TRANSPLANTATION; XENOGRAFT;

ANIMALIA; RATTUS;

ANIMALS; BIOTECHNOLOGY; CELL LINE; CELL SURVIVAL; CORPUS STRIATUM; CRYOPRESERVATION; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; FEMALE; HUMANS; MANUFACTURING INDUSTRY; NERVE FIBERS; NEURAL STEM CELLS; NEUROGENESIS; OXIDOPAMINE; PARKINSON DISEASE; PRACTICE GUIDELINES AS TOPIC; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84905567359     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.06.002     Document Type: Article

References (15)

1. Coelho M., Ferreira J.J. Late-stage Parkinson disease. Nat Rev Neurol 2012, 8:435-442.
2. Obeso J.A., Rodriguez-Oroz M.C., Goetz C.G., Marin C., Kordower J.H., Rodriguez M., et al. Missing pieces in the Parkinson's disease puzzle. Nat Med 2010, 16:653-661.
3. Politis M., Wu K., Loane C., Quinn N.P., Brooks D.J., Rehncrona S., et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med 2010, 2:38ra46.
4. Swistowski A., Peng J., Han Y., Swistowska A.M., Rao M.S., Zeng X. Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them. PLoS One 2009, 4:e6233.
5. Swistowska A.M., da Cruz A.B., Han Y., Swistowski A., Liu Y., Shin S., et al. Stage-specific role for shh in dopaminergic differentiation of human embryonic stem cells induced by stromal cells. Stem Cells Dev 2010, 19:71-82.
6. Swistowski A., Peng J., Liu Q., Mali P., Rao M.S., Cheng L., et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 2010, 28:1893-1904.
7. Liu Q., Pedersen O.Z., Peng J., Couture L.A., Rao M.S., Zeng X. Optimizing dopaminergic differentiation of pluripotent stem cells for the manufacture of dopaminergic neurons for transplantation. Cytotherapy 2013, 15:999-1010.
8. Peng J., Wu Z., Wu Y., Hsu M., Stevenson F.F., Boonplueang R., et al. Inhibition of caspases protects cerebellar granule cells of the weaver mouse from apoptosis and improves behavioral phenotype. J Biol Chem 2002, 277:44285-44291.
9. Peng J., Peng L., Stevenson F.F., Doctrow S.R., Andersen J.K. Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration. J Neurosci 2007, 27:6914-6922.
10. Kriks S., Shim J.W., Piao J., Ganat Y.M., Wakeman D.R., Xie Z., et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011, 480:547-551.
11. Gowing G., Shelley B., Staggenborg K., Hurley A., Avalos P., Victoroff J., et al. Glial cell line-derived neurotrophic factor-secreting human neural progenitors show long-term survival, maturation into astrocytes, and no tumor formation following transplantation into the spinal cord of immunocompromised rats. Neuroreport 2012, 25:367-372.
12. Zeng X., Cai J., Chen J., Luo Y., You Z.B., Fotter E., et al. Dopaminergic differentiation of human embryonic stem cells. Stem Cells 2004, 22:925-940.
13. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003, 54:403-414.
14. Lindvall O., Bjorklund A. Cell therapy in Parkinson's disease. NeuroRx 2004, 1:382-393.
15. Gowing G., Shelley B., Staggenborg K., Hurley A., Avalos P., Victoroff J., et al. Glial cell line-derived neurotrophic factor-secreting human neural progenitors show long-term survival, maturation into astrocytes, and no tumor formation following transplantation into the spinal cord of immunocompromised rats. Neuroreport 2014, 25:367-372.